Menu Back to Canada-Annual-Meeting


November 13-14: Meeting

The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical, medical device, and/or diagnostic landscapes in Canada, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory, Clinical and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory, clinical, and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices, lessons learned, and problem-solving strategies effecting stakeholders in Canada.

While we develop our 2023 agenda, please take a moment to review the 2022 final agenda.

NEW FOR 2023 – Call for Abstracts now open!

Are you a professional involved in the regulatory, clinical or pharmacovigilance functional areas within a company or organization working on pharmaceuticals, medical devices, and/or diagnostics in Canada? If so, DIA wants to hear from you! The Canada Annual Meeting Program Committee is seeking proposals for Presentations, Sessions, and Short Courses on the following topics of interest as it relates to our three tracks, Regulatory, Clinical, and Pharmacovigilance. Deadline to submit is Monday, April 17.

View Guidelines | Submit Here.

Need approval in order to attend? Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.

Participant Testimonials

Very insightful conference. Time well invested.” - Thierry Page, Executive VP, COO, Starpax Biopharma Inc.

“The best conference for Canadian content of 2022.” - Patricia Smith, Director, Regulatory Affairs, QA and PV, Otsuka Canada Pharmaceutical Inc.


Want to learn more about Canada Annual Meeting? You've come to the right site!
DIA Global Annual Meeting


View our Exhibit Partners and explore our latest offerings

Learn more
Generic Highlights

Highlights & Features

Stay in the know with what's going on at the event

Learn more

Who should attend?

  • Meeting Designed For

    Join professionals interested in a comprehensive overview of the current pharmaceuticals and device landscape in Canada:

    • Pharmacovigilance
    • Clinical Research, Management, Safety & Ops
    • Medical Affairs and Communication
    • Quality Assurance Control
    • Public/Corporate Policy & Regulatory Affairs
    • R&D and Risk Management
    • Project Management & eSubmissions
    • Real-World Evidence and Statistics

Program Committee

  • Maria  Anillo, MSc
    Maria Anillo, MSc Senior Associate, Established Products and Regulatory Operations
    Boehringer Ingelheim (Canada) Ltd., Canada
  • Marcia  Bailey, BSN, MHS, RN
    Marcia Bailey, BSN, MHS, RN Safety Evaluation & Risk Management Scientific Director
    GSK, Canada
  • Vatche  Bartekian, MSc
    Vatche Bartekian, MSc President
    Vantage BioTrials, Canada
  • Mandy  Collier
    Mandy Collier Director, Health Products and Food Branch
    Health Canada, Canada
  • Melanie  Cote, MS
    Melanie Cote, MS Senior Manager, Regulatory Affairs
    Otsuka Canada Pharmaceutical Inc., Canada
  • My  Dang
    My Dang Senior Manager, Regulatory Affairs and Quality Assurance
    Knight Therapeutics Inc. , Canada
  • Tharany  Ganesh, MSc
    Tharany Ganesh, MSc Director, Regulatory Affairs & Quality Assurance
    AstraZeneca Canada Inc., Canada
  • Lorella  Garofalo, PhD
    Lorella Garofalo, PhD Head of Regulatory Sciences
    Pfizer Canada, Canada
  • Marie-France  Goyer
    Marie-France Goyer Director, Clinical Operations
    Abcellera, Canada
  • Brenda  Gryfe, MSc
    Brenda Gryfe, MSc Director, Regulatory Affairs
    TPIreg/ Innomar Strategies, Canada
  • Oxana  Iliach, PhD
    Oxana Iliach, PhD Sr. Director, Regulatory Strategy
    Certara, Canada
  • Agnes  Jankowicz, MS
    Agnes Jankowicz, MS Vice President, Pharmacovigilance
    Veristat, Canada
  • Nadiya  Jirova
    Nadiya Jirova Manager, Bureau of Biologics, Radiopharmaceuticals and Self-Care Products, MHPD
    Health Canada, Canada
  • Yatika  Kohli, PhD, MBA
    Yatika Kohli, PhD, MBA Executive Director - Global Regulatory Affairs
    NoNO Inc, Canada
  • Myriam  Salem, MSc
    Myriam Salem, MSc Senior Corporate Regulatory and Enforcement Advisor
    Health Canada, Canada
  • Marcia  Sam
    Marcia Sam Regulatory Affairs Strategy and Policy Manager
    Hoffmann-La Roche Canada Limited, Canada
  • Vanessa  Zapata
    Vanessa Zapata Associate Director, Regional Pharmacovigilance Officer
    Merck Canada Inc., Canada
  • Zohra  Douida, MPharm, MS, MSc
    Zohra Douida, MPharm, MS, MSc Head, Regulatory Affairs Canada
    Indivior Canada Ltd., Canada
  • Amber  McLeod, PhD
    Amber McLeod, PhD Lead, Regulatory Affairs
    Abbvie Corporation, Canada
Load More